You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Impact of glycemic traits, type 2 diabetes and metformin use on breast and prostate cancer risk: a Mendelian randomization study

Article info

Article menu

Download PDFPDF

XML
Epidemiology/Health Services Research
Impact of glycemic traits, type 2 diabetes and metformin use on breast and prostate cancer risk: a Mendelian randomization study

Authors

  • Shiu Lun Au Yeung School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China PubMed articlesGoogle scholar articles
  • Catherine Mary Schooling School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, ChinaGraduate School of Public Health and Health Policy, City University of New York, New York City, New York, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Shiu Lun Au Yeung; ayslryan{at}hku.hk
View Full Text

Citation

Au Yeung SL, Schooling CM
Impact of glycemic traits, type 2 diabetes and metformin use on breast and prostate cancer risk: a Mendelian randomization study
BMJ Open Diabetes Research and Care 2019;7:e000872. doi: 10.1136/bmjdrc-2019-000872

Publication history

  • Received September 1, 2019
  • Revised November 12, 2019
  • Accepted December 3, 2019
  • First published December 29, 2019.
Online issue publication 
May 15, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.